Clinical Trial

Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

Recruiting
View on ClinicalTrials.gov →
Summary
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-30.
Trial Details
NCT Number NCT06535503
Lead Sponsor Abu Dhabi Health Services Company
Collaborators: Sheikh Shakhbout Medical City, Sheikh Khalifa Medical City
Conditions ST Elevation Myocardial Infarction, Cardiogenic Shock
Enrollment 400 participants
Start Date 2024-07-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-17